Web7. dec 2024 · December 28, 2024 updated by: PersonGen BioTherapeutics (Suzhou) Co., Ltd. This study is a clinical study of CD276 CAR-T in the treatment of patients with advanced solid tumors. The purpose is to evaluate the safety and effectiveness of targeting CD276 auto-chimeric antigen receptor T cells in the treatment of CD276-positive advanced solid … Web4. dec 2024 · PersonGen BioTherapeutics (Suzhou) Co., Ltd. ClinicalTrials.gov Identifier: NCT04186052 Other Study ID Numbers: PG-CART-BCMA-001 First Posted: Dec 4, 2024 Last Update Posted: Dec 4, 2024 Last Verified: Dec 1, 2024 Individual Participant Data (IPD) Sharing Statement: Undecided Plan to Share IPD: Undecided Studies a U.S. FDA-regulated …
CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
Web1 Clinical Research, PersonGen BioTherapeutics(Suzhou) Co., Ltd., 215000 - Suzhou/CN; 2 New Medicine Research, PersonGen BioTherapeutics(Suzhou) Co., Ltd., Suzhou/CN ... Web23. máj 2024 · On April 11, CDE’s official website revealed that the application for an Investigational New Drug, the new first-in-class [TAA06 Injection] by PersonGen … how do i get facetime
PersonGen BioTherapeutics Company Profile Management and …
Web31. dec 2024 · PersonGen BioTherapeutics (Suzhou) Co., Ltd. ClinicalTrials.gov Identifier: NCT04691713 Other Study ID Numbers: PG-CART-276-001 First Posted: Dec 31, 2024 Last Update Posted: Dec 31, 2024 Last Verified: Dec 1, 2024 Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH … Web31. dec 2024 · PersonGen BioTherapeutics (Suzhou) Co., Ltd. Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record Study Description Go to Brief … Web3 Persongen Biomedicine (Suzhou) Co., Ltd, Suzhou, 215123, China. 4 West China Hospital, Sichuan University, Chengdu, 610041, China. 5 Department of Cardiothoracic Surgery, … how much is the iced caramel macchiato